PURPOSE Cisplatin is widely used and highly ototoxic, but patient-reported functional
impairment because of cisplatin-related hearing loss (HL) and tinnitus has not been …

Objectives: To provide new information on factors associated with discrepancies between
patient-reported and audiometrically defined hearing loss (HL) in adult-onset cancer …

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based
Chemotherapy in Survivors of Adult-Onset Cancer - PMC Back to Top Skip to main content NIH …

Background: Hearing loss is a well-known long-term effect after cisplatin-based
chemotherapy (CBCT) in testicular cancer survivors (TCS), but longitudinal data are sparse …

Objective: To identify any change in quality of life (QoL) caused by chemotherapy-induced
toxicities, such as hearing loss and tinnitus, to provide information in order to improve …

In the article that accompanies this editorial, Frisina et al 1 report on ototoxicity after cisplatin-
based chemotherapy in the Platinum Study. This study comprehensively assesses hearing …

Objectives Cisplatin‐related hearing loss (HL) is claimed to progress after treatment. This
controlled longitudinal study with extended follow‐up investigates HL in testicular cancer …

Cisplatin is a bedrock of cancer management and one of the most used chemotherapeutic
agents in the treatment of germ cell, lung, bladder, ovarian, and head and neck cancers …

Background: Cisplatin is one of the anticancer drugs used for head and neck cancers.
Although some studies have shown that cisplatin can cause ototoxicity, periodic audiometric …

Purpose Cisplatin is a critical component of first‐line chemotherapy for several cancers, but
causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify …